TickerKhojComparison · NSE · data 2026-11-02
Aarti Pharmalabs Limited vs Sanofi India Limited
In plain words
Size: Aarti Pharmalabs Limited is about 1.1 times the market value of Sanofi India Limited.
Valuation (P/E): Aarti Pharmalabs Limited 31.4 vs Sanofi India Limited 20.8.
Return on equity: Sanofi India Limited 40.6% vs Aarti Pharmalabs Limited 8.5%.
Profit growth over 3 years: Aarti Pharmalabs Limited -3.3% a year vs Sanofi India Limited -19.3% a year.
Debt to equity: Aarti Pharmalabs Limited 0.36 vs Sanofi India Limited 0.02.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AARTIPHARM | SANOFI | |
|---|---|---|
| Price | ₹887.95 | ₹3,289.3 |
| Market cap | ₹7,922 cr | ₹7,380 cr |
| P/E | 31.4 | 20.8 |
| P/B | 3.6 | — |
| ROE | 8.5% | 40.6% |
| ROCE | 11.5% | 54.6% |
| Debt / equity | 0.36 | 0.02 |
| Operating margin | 17.7% | 26.3% |
| Dividend yield | 0.40% | 3.84% |
| Sales growth, 3 years (yearly) | -2.6% | -12.8% |
| Profit growth, 3 years (yearly) | -3.3% | -19.3% |
| 1-year return | 6.2% | -31.5% |
| Revenue, last 12 months | ₹2,161 cr | ₹1,822 cr |
| Net profit, last 12 months | ₹257 cr | ₹365 cr |
| Latest quarter | Sept 2026 | Sept 2026 |
| Quarter net profit | ₹69 cr | ₹117 cr |
| Quarter profit vs a year earlier | +141.2% | +53.6% |
| Promoter holding | 39.66% | 60.40% |
| Health check | Average (6.1/10) | Average (6.3/10) |
Common questions
Which has a higher P/E, Aarti Pharmalabs Limited or Sanofi India Limited?
Aarti Pharmalabs Limited trades at the higher P/E (31.4 against 20.8). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Sanofi India Limited (40.6% against 8.5%).
Which carries more debt?
Aarti Pharmalabs Limited has the higher debt-to-equity ratio (0.36 against 0.02).